Price movement over the last 24 hours
ABM Investama Tbk vs Champion Pacific Indonesia Tbk. — how do they compare? ABM Investama Tbk trades at Rp2,290 (market cap 6.3T, 238.5K 24h volume), while Champion Pacific Indonesia Tbk. trades at Rp406 (market cap 385.96B, 6.7K 24h volume). The key difference: ABM Investama Tbk is far larger — about 16.3× Champion Pacific Indonesia Tbk.'s market cap, and ABM Investama Tbk is more actively traded (238.5K versus 6.7K). Which is the better fit depends on your goals.
| ABMM | IGAR | |
|---|---|---|
Market Cap | 6.3T | 385.96B |
Volume | 238.5K | 6.7K |
Lot | 2.39K | 67 |
Turnover | 547.11M | 2.74M |
Average Price | 2,293.95 | 408.9 |
Value | 547.11M | 2.74M |
Indicative Equilibrium Price | 2,290 | 420 |
Indicative Equilibrium Volume | 29 | 3 |
Trailing returns across standard periods
Latest headlines on both assets
ABM Investama, PT (the company) was established under its original name of PT Adiratna Bani Makmur on Jun 1, 2006 then changed to PT ABM Investama Tbk based on Notaries Deed dated Aug 31, 2009. The deed of establishment was approved by the the Ministry of Justice dated Oct 16, 2009. The Company’s articles of association has been amended several times, most recently by notarial deed No. 163 of Mrs. Aulia Taufani, S.H., dated Jul 21, 2011, concerning among others, public offering of stock.
Read more on ABMM →PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.
Read more on IGAR →